Evidence map›Paper›PMID 42459433›Full record

ArticleIranian journal of parasitology

Masoud Foroutan, Hamidreza Majidiani, Fatemeh Ghaffarifar, Elaheh Karimzadeh-Soureshjani, Amir Karimipour-Saryazdi, Ali Dalir Ghaffari, John Horton

Abstract read
In one paragraph

Article in Iranian journal of parasitology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Masoud ForoutanDepartment of Basic Medical Sciences, Faculty of Medicine, Abadan University of Medical Sciences, Abadan, Iran.
Hamidreza MajidianiHealthy Aging Research Centre, Neyshabur University of Medical Sciences, Neyshabur, Iran.
Fatemeh GhaffarifarDepartment of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Elaheh Karimzadeh-SoureshjaniStudent Research Committee, Abadan University of Medical Sciences, Abadan, Iran.
Amir Karimipour-SaryazdiDepartment of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Ali Dalir GhaffariDepartment of Parasitology and Mycology, Faculty of Medicine, Shahed University, Tehran, Iran.
John HortonTropical Projects, Hitchin, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Microneme protein 3 (MIC3) is a key adhesion molecule in Methods: A comprehensive set of bioinformatics tools and web servers was employed to predict the physicochemical properties, allergenicity, antigenicity, solubility, post-translational modification sites, subcellular localization, transmembrane domains, signal peptides, secondary and tertiary structures, potential B- and T-lymphocyte epitopes, and simulated immune responses of the TgMIC3 protein. Results: A total of 75 post-translational modification sites were predicted in TgMIC3. Furthermore, secondary structure analysis using GOR IV, SOPMA, and NetSurfP-3.0 indicated that random coils and extended strands were the predominant structural elements. In addition, several high-affinity B- and T-cell epitopes were identified across the protein sequence. Subsequent structural validation revealed that 82.91% and 98.60% of residues were located in favored regions in the initial and refined 3D models, respectively. The findings of the allergenicity and antigenicity assessments indicated that the MIC3 antigen seemed to be a non-allergen with an immunogenic nature. Moreover, immune simulation using the C-ImmSim server demonstrated that TgMIC3 could induce robust humoral and cell-mediated immune responses following three simulated antigen administrations.

Indexed as

BioinformaticsIn silicoMicroneme proteinsToxoplasma gondiiVaccine

Identifiers

PMID42459433
PMCPMC13369592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.